{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:12:03Z","timestamp":1785510723443,"version":"3.56.0"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023MH127"],"award-info":[{"award-number":["ZR2023MH127"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015507","name":"Shandong First Medical University","doi-asserted-by":"publisher","award":["2019QL013"],"award-info":[{"award-number":["2019QL013"]}],"id":[{"id":"10.13039\/501100015507","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.prp.2026.156423","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:16:31Z","timestamp":1771978591000},"page":"156423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Astragaloside IV ameliorates experimental autoimmune myasthenia gravis through multi-target regulation of immune-microbiota-metabolism network and ferroptosis inhibition"],"prefix":"10.1016","volume":"282","author":[{"given":"Lin","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4385-3591","authenticated-orcid":false,"given":"Yanbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"26","key":"10.1016\/j.prp.2026.156423_bib1","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.prp.2026.156423_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.25122\/jml-2020-0145","article-title":"The epidemiology of myasthenia gravis","volume":"14","author":"Bubuioc","year":"2021","journal-title":"J. Med Life"},{"issue":"3","key":"10.1016\/j.prp.2026.156423_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/clin.1997.4412","article-title":"Epidemiology and estimated population burden of selected autoimmune diseases in the United States","volume":"84","author":"Jacobson","year":"1997","journal-title":"Clin. Immunol. Immunopathol."},{"issue":"11","key":"10.1016\/j.prp.2026.156423_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10112235","article-title":"Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations","volume":"10","author":"Dresser","year":"2021","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.prp.2026.156423_bib5","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.23043","article-title":"Structural insights into the molecular mechanisms of myasthenia gravis and their therapeutic implications","volume":"6","author":"Noridomi","year":"2017","journal-title":"Elife"},{"issue":"44","key":"10.1016\/j.prp.2026.156423_bib6","doi-asserted-by":"crossref","first-page":"13898","DOI":"10.1523\/JNEUROSCI.2833-09.2009","article-title":"Main immunogenic region structure promotes binding of conformation-dependent myasthenia gravis autoantibodies, nicotinic acetylcholine receptor conformation maturation, and agonist sensitivity","volume":"29","author":"Luo","year":"2009","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.prp.2026.156423_bib7","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S1474-4422(17)30369-1","article-title":"Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study","volume":"16","author":"Howard","year":"2017","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.prp.2026.156423_bib8","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S1474-4422(21)00159-9","article-title":"Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial","volume":"20","author":"Howard","year":"2021","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.prp.2026.156423_bib9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1474-4422(24)00498-8","article-title":"Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study","volume":"24","author":"Antozzi","year":"2025","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.prp.2026.156423_bib10","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s00415-025-12922-7","article-title":"Myasthenia gravis in 2025: five new things and four hopes for the future","volume":"272","author":"Binks","year":"2025","journal-title":"J. Neurol."},{"issue":"5","key":"10.1016\/j.prp.2026.156423_bib11","first-page":"613","article-title":"[AChR antibody-positive myasthenia gravis]","volume":"76","author":"Murai","year":"2024","journal-title":"Brain Nerve"},{"key":"10.1016\/j.prp.2026.156423_bib12","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3389\/fimmu.2020.00707","article-title":"Muscle-specific kinase myasthenia gravis","volume":"11","author":"Borges","year":"2020","journal-title":"Front Immunol."},{"issue":"12","key":"10.1016\/j.prp.2026.156423_bib13","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1172\/JCI66039","article-title":"Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis","volume":"123","author":"Shen","year":"2013","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.prp.2026.156423_bib14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2013.12.011","article-title":"Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms","volume":"52","author":"Berrih-Aknin","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.prp.2026.156423_bib15","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.3389\/fimmu.2017.01370","article-title":"A sensitive method for detecting peptide-specific CD4(+) T cell responses in peripheral blood from patients with myasthenia gravis","volume":"8","author":"Sharma","year":"2017","journal-title":"Front Immunol."},{"issue":"5","key":"10.1016\/j.prp.2026.156423_bib16","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.4049\/jimmunol.1501339","article-title":"Autoreactive T cells from patients with myasthenia gravis are characterized by elevated IL-17, IFN-\u03b3, and GM-CSF and diminished IL-10 production","volume":"196","author":"Cao","year":"2016","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.prp.2026.156423_bib17","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nri3738","article-title":"Regional specialization within the intestinal immune system","volume":"14","author":"Mowat","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"18","key":"10.1016\/j.prp.2026.156423_bib18","article-title":"Perturbed microbial ecology in myasthenia gravis: evidence from the gut microbiome and fecal metabolome","volume":"6","author":"Zheng","year":"2019","journal-title":"Adv. Sci. (Weinh. )"},{"issue":"8","key":"10.1016\/j.prp.2026.156423_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/nu14081647","article-title":"Exploring the gut microbiome in myasthenia gravis","volume":"14","author":"Thye","year":"2022","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.prp.2026.156423_bib20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12964-024-01588-9","article-title":"Gut microbiota-derived butyrate restores impaired regulatory T cells in patients with AChR myasthenia gravis via mTOR-mediated autophagy","volume":"22","author":"He","year":"2024","journal-title":"Cell Commun. Signal"},{"issue":"1","key":"10.1016\/j.prp.2026.156423_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/icb.2014.75","article-title":"Keeping the immune system in check: a role for mitophagy","volume":"93","author":"Lazarou","year":"2015","journal-title":"Immunol. Cell Biol."},{"issue":"23","key":"10.1016\/j.prp.2026.156423_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315052","article-title":"Opposite regulation of homer signal at the NMJ postsynaptic micro domain between slow- and fast-twitch muscles in an experimentally induced autoimmune myasthenia gravis (EAMG) mouse model","volume":"23","author":"Schubert","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2026.156423_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2023.578015","article-title":"Iron metabolism in non-anemic myasthenia gravis patients: a cohort study","volume":"375","author":"Li","year":"2023","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.prp.2026.156423_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/bs.apha.2019.08.002","article-title":"Astragaloside IV derived from Astragalus membranaceus: a research review on the pharmacological effects","volume":"87","author":"Zhang","year":"2020","journal-title":"Adv. Pharm."},{"key":"10.1016\/j.prp.2026.156423_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1065505","article-title":"Astragaloside IV, as a potential anticancer agent","volume":"14","author":"Xia","year":"2023","journal-title":"Front Pharm."},{"issue":"1","key":"10.1016\/j.prp.2026.156423_bib26","doi-asserted-by":"crossref","first-page":"17497","DOI":"10.1038\/s41598-024-68462-z","article-title":"Astragaloside IV protects brain cells from ischemia-reperfusion injury by inhibiting ryanodine receptor expression and reducing the expression of P-Src and P-GRK2","volume":"14","author":"Chen","year":"2024","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.prp.2026.156423_bib27","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s11418-025-01892-9","article-title":"Insight of action mechanism of Astragaloside IV for relieving of cerebral ischemic injury in a rat model of middle cerebral artery occlusion reperfusion via proteomics and network pharmacology","volume":"79","author":"Zhu","year":"2025","journal-title":"J. Nat. Med"},{"key":"10.1016\/j.prp.2026.156423_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114229","article-title":"Astragaloside IV: a promising natural neuroprotective agent for neurological disorders","volume":"159","author":"Yao","year":"2023","journal-title":"Biomed. Pharm."},{"issue":"21","key":"10.1016\/j.prp.2026.156423_bib29","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1080\/15384101.2022.2093598","article-title":"Astragaloside IV attenuate MI-induced myocardial fibrosis and cardiac remodeling by inhibiting ROS\/caspase-1\/GSDMD signaling pathway","volume":"21","author":"Zhang","year":"2022","journal-title":"Cell Cycle"},{"key":"10.1016\/j.prp.2026.156423_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114598","article-title":"The beneficial effects of astragaloside IV on ameliorating diabetic kidney disease","volume":"163","author":"Gao","year":"2023","journal-title":"Biomed. Pharm."},{"issue":"1","key":"10.1016\/j.prp.2026.156423_bib31","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/s12967-024-05168-w","article-title":"Blockade of PI3K\/AKT signaling pathway by Astragaloside IV attenuates ulcerative colitis via improving the intestinal epithelial barrier","volume":"22","author":"Zhang","year":"2024","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.prp.2026.156423_bib32","article-title":"Astragaloside IV alleviates septic myocardial injury through DUSP1-Prohibitin 2 mediated mitochondrial quality control and ER-autophagy","author":"Wang","year":"2024","journal-title":"J. Adv. Res"},{"issue":"16","key":"10.1016\/j.prp.2026.156423_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28166118","article-title":"Pharmacological effects of astragaloside IV: a review","volume":"28","author":"Liang","year":"2023","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.prp.2026.156423_bib34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13020-023-00798-6","article-title":"Astragaloside IV ameliorates experimental autoimmune myasthenia gravis by regulating CD4\u2009+\u2009T cells and altering gut microbiota","volume":"18","author":"Weng","year":"2023","journal-title":"Chin. Med"},{"issue":"6","key":"10.1016\/j.prp.2026.156423_bib35","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1084\/jem.141.6.1365","article-title":"Experimental autoimmune myasthenia: a model of myasthenia gravis in rats and guinea pigs","volume":"141","author":"Lennon","year":"1975","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.prp.2026.156423_bib36","article-title":"Regulatory T cell function in autoimmune disease","volume":"4","author":"Rajendeeran","year":"2021","journal-title":"J. Transl. Autoimmun."},{"issue":"3","key":"10.1016\/j.prp.2026.156423_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/cells9030531","article-title":"Memory CD4(+) T Cells in Immunity and Autoimmune Diseases","volume":"9","author":"Raphael","year":"2020","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.prp.2026.156423_bib38","article-title":"T-Follicular Helper Cells and Their Role in Autoimmune Diseases","volume":"15","author":"Christodoulou","year":"2025","journal-title":"Life (Basel)"},{"key":"10.1016\/j.prp.2026.156423_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.20517\/cdr.2024.151","article-title":"Ferroptosis-related signaling pathways in cancer drug resistance","volume":"8","author":"Yang","year":"2025","journal-title":"Cancer Drug Resist"},{"issue":"1","key":"10.1016\/j.prp.2026.156423_bib40","doi-asserted-by":"crossref","DOI":"10.4110\/in.2025.25.e6","article-title":"Regulation of Ferroptosis in Cancer and Immune Cells","volume":"25","author":"Jang","year":"2025","journal-title":"Immune Netw."},{"issue":"1","key":"10.1016\/j.prp.2026.156423_bib41","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12974-025-03486-4","article-title":"Hypothalamic kisspeptin alleviates myasthenia gravis by regulating Th1\/Th17\/Treg balance through Inhibition of NF-\u03baB signaling pathway","volume":"22","author":"Lu","year":"2025","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.prp.2026.156423_bib42","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1749-6632.2012.06791.x","article-title":"Defects of immunoregulatory mechanisms in myasthenia gravis: role of IL-17","volume":"1274","author":"Gradolatto","year":"2012","journal-title":"Ann. N. Y Acad. Sci."},{"issue":"1","key":"10.1016\/j.prp.2026.156423_bib43","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12974-024-03095-7","article-title":"Thymic gene expression analysis reveals a potential link between HIF-1A and Th17\/Treg imbalance in thymoma associated myasthenia gravis","volume":"21","author":"Alt\u0131n\u00f6nder","year":"2024","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.prp.2026.156423_bib44","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1196\/annals.1443.021","article-title":"Regulation and function of proinflammatory TH17 cells","volume":"1143","author":"Martinez","year":"2008","journal-title":"Ann. N. Y Acad. Sci."},{"issue":"3","key":"10.1016\/j.prp.2026.156423_bib45","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/cei.13546","article-title":"Roles of cytokines and T cells in the pathogenesis of myasthenia gravis","volume":"203","author":"Uzawa","year":"2021","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.prp.2026.156423_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.593431","article-title":"Immunoregulatory Cells in Myasthenia Gravis","volume":"11","author":"Wu","year":"2020","journal-title":"Front Neurol."},{"key":"10.1016\/j.prp.2026.156423_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123162","article-title":"Circulating CD45RA(-)Foxp3(++) Treg cells serve as a biomarker for predicting minimal clinical manifestations status of myasthenia gravis","volume":"358","author":"Lu","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2026.156423_bib48","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.expneurol.2018.11.006","article-title":"Tacrolimus inhibits Th1 and Th17 responses in MuSK-antibody positive myasthenia gravis patients","volume":"312","author":"Li","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.prp.2026.156423_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.641013","article-title":"Frontiers of Autoantibodies in Autoimmune Disorders: Crosstalk Between Tfh\/Tfr and Regulatory B Cells","volume":"12","author":"Ding","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.prp.2026.156423_bib50","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.3389\/fimmu.2018.01793","article-title":"Follicular Helper T Cells in Systemic Lupus Erythematosus","volume":"9","author":"Kim","year":"2018","journal-title":"Front Immunol."},{"issue":"6","key":"10.1016\/j.prp.2026.156423_bib51","doi-asserted-by":"crossref","first-page":"R255","DOI":"10.1186\/ar4100","article-title":"A regulatory effect of IL-21 on T follicular helper-like cell and B cell in rheumatoid arthritis","volume":"14","author":"Liu","year":"2012","journal-title":"Arthritis Res Ther."},{"issue":"2","key":"10.1016\/j.prp.2026.156423_bib52","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000945","article-title":"Immune Skew of Circulating Follicular Helper T Cells Associates With Myasthenia Gravis Severity","volume":"8","author":"Ashida","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.prp.2026.156423_bib53","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12974-019-1687-x","article-title":"CXCR5-negative natural killer cells ameliorate experimental autoimmune myasthenia gravis by suppressing follicular helper T cells","volume":"16","author":"Yang","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.prp.2026.156423_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2025.103395","article-title":"Peripheral immune profiling highlights a dynamic role of low-density granulocytes in myasthenia gravis","volume":"152","author":"Zhang","year":"2025","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.prp.2026.156423_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2024.578464","article-title":"Pathogenic Th17 cells are a potential therapeutic target for tacrolimus in AChR-myasthenia gravis patients","volume":"396","author":"Li","year":"2024","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.prp.2026.156423_bib56","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s13578-023-01163-8","article-title":"Causal relationship between gut microbiota and myasthenia gravis: a bidirectional mendelian randomization study","volume":"13","author":"Su","year":"2023","journal-title":"Cell Biosci."},{"key":"10.1016\/j.prp.2026.156423_bib57","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.3389\/fmicb.2018.02627","article-title":"Altered Gut Microbiota in Myasthenia Gravis","volume":"9","author":"Qiu","year":"2018","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.prp.2026.156423_bib58","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/nyas.13567","article-title":"Gut microbiota and probiotics: novel immune system modulators in myasthenia gravis?","volume":"1413","author":"Rinaldi","year":"2018","journal-title":"Ann. N. Y Acad. Sci."},{"issue":"10","key":"10.1016\/j.prp.2026.156423_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms8101587","article-title":"Gut Microbiota and Immune System Interactions","volume":"8","author":"Yoo","year":"2020","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.prp.2026.156423_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms5010001","article-title":"Improvement of Intestinal Immune Cell Function by Lactic Acid Bacteria for Dairy Products","volume":"5","author":"Kamiya","year":"2016","journal-title":"Microorganisms"},{"key":"10.1016\/j.prp.2026.156423_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.840245","article-title":"Lactobacillus spp. for Gastrointestinal Health: Current and Future Perspectives","volume":"13","author":"Dempsey","year":"2022","journal-title":"Front Immunol."},{"issue":"11","key":"10.1016\/j.prp.2026.156423_bib62","article-title":"Contribution of Lactobacilli on Intestinal Mucosal Barrier and Diseases: Perspectives and Challenges of Lactobacillus casei","volume":"12","author":"Qin","year":"2022","journal-title":"Life (Basel)"},{"issue":"1","key":"10.1016\/j.prp.2026.156423_bib63","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3390\/neurolint15010026","article-title":"The Role of Human Microbiota in Myasthenia Gravis: A Narrative Review","volume":"15","author":"Schir\u00f2","year":"2023","journal-title":"Neurol. Int"},{"issue":"32","key":"10.1016\/j.prp.2026.156423_bib64","doi-asserted-by":"crossref","first-page":"22269","DOI":"10.18632\/oncotarget.25170","article-title":"Administration of bifidobacterium and lactobacillus strains modulates experimental myasthenia gravis and experimental encephalomyelitis in Lewis rats","volume":"9","author":"Consonni","year":"2018","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.prp.2026.156423_bib65","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.clnu.2016.08.015","article-title":"Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial","volume":"36","author":"Kouchaki","year":"2017","journal-title":"Clin. Nutr."},{"issue":"45","key":"10.1016\/j.prp.2026.156423_bib66","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202004529","article-title":"Prebiotics-Encapsulated Probiotic Spores Regulate Gut Microbiota and Suppress Colon Cancer","volume":"32","author":"Zheng","year":"2020","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.prp.2026.156423_bib67","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2020.1802866","article-title":"Gut microbes from the phylogenetically diverse genus Eubacterium and their various contributions to gut health","volume":"12","author":"Mukherjee","year":"2020","journal-title":"Gut Microbes"},{"issue":"5","key":"10.1016\/j.prp.2026.156423_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens13050409","article-title":"The impact of Enterococcus spp. in the immunocompromised host: a comprehensive review","volume":"13","author":"Sangiorgio","year":"2024","journal-title":"Pathogens"},{"issue":"2","key":"10.1016\/j.prp.2026.156423_bib69","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1186\/ar2662","article-title":"Anti-inflammatory and antiarthritic effects of piperine in human interleukin 1beta-stimulated fibroblast-like synoviocytes and in rat arthritis models","volume":"11","author":"Bang","year":"2009","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.prp.2026.156423_bib70","doi-asserted-by":"crossref","DOI":"10.1007\/s00210-025-04220-w","article-title":"Harmaline attenuates pain and inflammation: role of IL-1\u03b2, oxidative stress, nitric oxide and cyclo-oxygenase","author":"Chaubey","year":"2025","journal-title":"Naunyn Schmiede Arch. Pharm."},{"issue":"1","key":"10.1016\/j.prp.2026.156423_bib71","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4062\/biomolther.2012.091","article-title":"3,4,5-Trihydroxycinnamic Acid Inhibits Lipopolysaccharide-Induced Inflammatory Response through the Activation of Nrf2 Pathway in BV2 Microglial Cells","volume":"21","author":"Lee","year":"2013","journal-title":"Biomol. Ther. (Seoul. )"},{"issue":"24","key":"10.1016\/j.prp.2026.156423_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/nu14245383","article-title":"p-Hydroxybenzoic Acid Ameliorates Colitis by Improving the Mucosal Barrier in a Gut Microbiota-Dependent Manner","volume":"14","author":"Han","year":"2022","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.prp.2026.156423_bib73","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13018-022-03006-7","article-title":"The protective effect of gentisic acid on rheumatoid arthritis via the RAF\/ERK signaling pathway","volume":"17","author":"Dong","year":"2022","journal-title":"J. Orthop. Surg. Res"},{"issue":"4","key":"10.1016\/j.prp.2026.156423_bib74","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1007\/s10787-024-01512-0","article-title":"Novel antiarthritic mechanisms of Azelaic acid against CFA-induced arthritis in rats by modulating pro- and anti-inflammatory cytokines network","volume":"32","author":"Sial","year":"2024","journal-title":"Inflammopharmacology"},{"issue":"10","key":"10.1016\/j.prp.2026.156423_bib75","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1177\/0960327115618245","article-title":"Anti-inflammatory and proapoptotic effects of umbelliferone in colon carcinogenesis","volume":"35","author":"Muthu","year":"2016","journal-title":"Hum. Exp. Toxicol."},{"issue":"7","key":"10.1016\/j.prp.2026.156423_bib76","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1039\/C8FO02338G","article-title":"Docosapentaenoic acid (DPA, 22:5n-3) ameliorates inflammation in an ulcerative colitis model","volume":"10","author":"Zheng","year":"2019","journal-title":"Food Funct."},{"key":"10.1016\/j.prp.2026.156423_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120742","article-title":"3,4-Dihydroxyphenylacetic acid ameliorates gut barrier dysfunction via regulation of MAPK-MLCK pathway in type 2 diabetes mice","volume":"305","author":"Liu","year":"2022","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.prp.2026.156423_bib78","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.7150\/thno.40128","article-title":"Soyasaponin II protects against acute liver failure through diminishing YB-1 phosphorylation and Nlrp3-inflammasome priming in mice","volume":"10","author":"Wang","year":"2020","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.prp.2026.156423_bib79","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.70073","article-title":"Formoterol Reduces the Pro-Inflammatory Phenotype by Enhancing the Activity of Glutaminase in Monocyte-Derived Macrophages in the CVB3-Induced Viral Myocarditis","volume":"12","author":"Li","year":"2024","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.prp.2026.156423_bib80","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s40104-019-0379-9","article-title":"Putrescine mitigates intestinal atrophy through suppressing inflammatory response in weanling piglets","volume":"10","author":"Liu","year":"2019","journal-title":"J. Anim. Sci. Biotechnol."},{"issue":"1","key":"10.1016\/j.prp.2026.156423_bib81","doi-asserted-by":"crossref","first-page":"18853","DOI":"10.1038\/s41598-024-69028-9","article-title":"Eriodictyol attenuates osteoarthritis progression through inhibiting inflammation via the PI3K\/AKT\/NF-\u03baB signaling pathway","volume":"14","author":"Kang","year":"2024","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.prp.2026.156423_bib82","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23368","article-title":"Eriodictyol regulated ferroptosis, mitochondrial dysfunction, and cell viability via Nrf2\/HO-1\/NQO1 signaling pathway in ovarian cancer cells","volume":"37","author":"Wang","year":"2023","journal-title":"J. Biochem Mol. Toxicol."},{"issue":"1","key":"10.1016\/j.prp.2026.156423_bib83","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s10020-022-00442-3","article-title":"Eriodictyol ameliorates cognitive dysfunction in APP\/PS1 mice by inhibiting ferroptosis via vitamin D receptor-mediated Nrf2 activation","volume":"28","author":"Li","year":"2022","journal-title":"Mol. Med"},{"issue":"5","key":"10.1016\/j.prp.2026.156423_bib84","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/cen.13946","article-title":"Serum polyamine metabolic profile in autoimmune thyroid disease patients","volume":"90","author":"Song","year":"2019","journal-title":"Clin. Endocrinol. (Oxf. )"},{"key":"10.1016\/j.prp.2026.156423_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1398653","article-title":"Genetically predicted N-Acetyl-L-Alanine mediates the association between CD3 on activated and secreting Tregs and Guillain-Barre syndrome","volume":"18","author":"Lyu","year":"2024","journal-title":"Front Neurosci."},{"issue":"3","key":"10.1016\/j.prp.2026.156423_bib86","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2141.1985.tb07446.x","article-title":"The iron-chelating agent picolinic acid enhances transferrin receptors expression in human erythroleukaemic cell lines","volume":"60","author":"Testa","year":"1985","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.prp.2026.156423_bib87","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s43556-023-00142-2","article-title":"The mechanism of ferroptosis and its related diseases","volume":"4","author":"Feng","year":"2023","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.prp.2026.156423_bib88","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.87316","article-title":"Uremic toxin indoxyl sulfate induces trained immunity via the AhR-dependent arachidonic acid pathway in end-stage renal disease (ESRD)","volume":"12","author":"Kim","year":"2024","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.prp.2026.156423_bib89","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","article-title":"Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.prp.2026.156423_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1225494","article-title":"Thyroid hormones and minerals in immunocorrection of disorders in autoimmune thyroid diseases","volume":"14","author":"Kravchenko","year":"2023","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.prp.2026.156423_bib91","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13075-023-03071-1","article-title":"Dopamine D2 receptor on CD4(+) T cells is protective against inflammatory responses and signs in a mouse model of rheumatoid arthritis","volume":"25","author":"Wang","year":"2023","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.prp.2026.156423_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102760","article-title":"Energy stress modulation of AMPK\/FoxO3 signaling inhibits mitochondria-associated ferroptosis","volume":"63","author":"Zhong","year":"2023","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.prp.2026.156423_bib93","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/13880209.2021.2007269","article-title":"Britanin relieves ferroptosis-mediated myocardial ischaemia\/reperfusion damage by upregulating GPX4 through activation of AMPK\/GSK3\u03b2\/Nrf2 signalling","volume":"60","author":"Lu","year":"2022","journal-title":"Pharm. Biol."},{"issue":"15","key":"10.1016\/j.prp.2026.156423_bib94","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/j.cub.2018.05.094","article-title":"AMPK-Mediated BECN1 Phosphorylation Promotes Ferroptosis by Directly Blocking System X(c)(-) Activity","volume":"28","author":"Song","year":"2018","journal-title":"Curr. Biol."},{"issue":"5","key":"10.1016\/j.prp.2026.156423_bib95","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.cell.2024.01.030","article-title":"Phospholipids with two polyunsaturated fatty acyl tails promote ferroptosis","volume":"187","author":"Qiu","year":"2024","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.prp.2026.156423_bib96","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/jcsm.12700","article-title":"Transferrin receptor 1 ablation in satellite cells impedes skeletal muscle regeneration through activation of ferroptosis","volume":"12","author":"Ding","year":"2021","journal-title":"J. Cachex.. Sarcopenia Muscle"},{"issue":"2","key":"10.1016\/j.prp.2026.156423_bib97","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1600-0609.1995.tb01826.x","article-title":"Myasthenia gravis following iron chelation therapy with intravenous desferrioxamine","volume":"55","author":"Krishnan","year":"1995","journal-title":"Eur. J. Haematol."},{"issue":"18","key":"10.1016\/j.prp.2026.156423_bib98","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201800311","article-title":"GPX4 at the crossroads of lipid homeostasis and ferroptosis","volume":"19","author":"Forcina","year":"2019","journal-title":"Proteomics"},{"issue":"1","key":"10.1016\/j.prp.2026.156423_bib99","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/ars.2017.7115","article-title":"GPx4, lipid peroxidation, and cell death: discoveries, rediscoveries, and open issues","volume":"29","author":"Maiorino","year":"2018","journal-title":"Antioxid. Redox Signal"},{"issue":"5","key":"10.1016\/j.prp.2026.156423_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2006203","article-title":"Unsolved mysteries: how does lipid peroxidation cause ferroptosis?","volume":"16","author":"Feng","year":"2018","journal-title":"PLoS Biol."},{"issue":"1-2","key":"10.1016\/j.prp.2026.156423_bib101","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41417-020-0182-y","article-title":"Interplay between MTOR and GPX4 signaling modulates autophagy-dependent ferroptotic cancer cell death","volume":"28","author":"Liu","year":"2021","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.prp.2026.156423_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101947","article-title":"NOX4 promotes ferroptosis of astrocytes by oxidative stress-induced lipid peroxidation via the impairment of mitochondrial metabolism in Alzheimer's diseases","volume":"41","author":"Park","year":"2021","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.prp.2026.156423_bib103","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1186\/s12935-021-02420-x","article-title":"FTH promotes the proliferation and renders the HCC cells specifically resist to ferroptosis by maintaining iron homeostasis","volume":"21","author":"Hu","year":"2021","journal-title":"Cancer Cell Int"},{"issue":"3","key":"10.1016\/j.prp.2026.156423_bib104","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s12035-023-03640-0","article-title":"Mechanisms of ferritinophagy and ferroptosis in diseases","volume":"61","author":"Li","year":"2024","journal-title":"Mol. Neurobiol."},{"issue":"21","key":"10.1016\/j.prp.2026.156423_bib105","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1097\/CM9.0000000000002533","article-title":"Acyl-CoA synthase ACSL4: an essential target in ferroptosis and fatty acid metabolism","volume":"136","author":"Ding","year":"2023","journal-title":"Chin. Med J. (Engl. )"},{"issue":"2","key":"10.1016\/j.prp.2026.156423_bib106","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1021\/acschembio.2c00869","article-title":"Ferroptosis inhibitors suppress prostaglandin synthesis in lipopolysaccharide-stimulated macrophages","volume":"18","author":"Aleem","year":"2023","journal-title":"ACS Chem. Biol."},{"issue":"3","key":"10.1016\/j.prp.2026.156423_bib107","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s12035-021-02706-1","article-title":"COX-2\/PGE2 pathway inhibits the ferroptosis induced by cerebral ischemia reperfusion","volume":"59","author":"Xu","year":"2022","journal-title":"Mol. Neurobiol."},{"issue":"7","key":"10.1016\/j.prp.2026.156423_bib108","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.7150\/ijbs.103971","article-title":"Theaflavins attenuate iron overload-induced liver oxidative injury by inhibiting hepatocyte ferroptosis","volume":"21","author":"Chen","year":"2025","journal-title":"Int J. Biol. Sci."},{"key":"10.1016\/j.prp.2026.156423_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116512","article-title":"GPX4, ferroptosis, and diseases","volume":"174","author":"Zhang","year":"2024","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.prp.2026.156423_bib110","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.2147\/CMAR.S483526","article-title":"The high expression of SLC7A11 and GPX4 are significantly correlated with \u03b2-catenin in colorectal cancer","volume":"16","author":"Ou","year":"2024","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.prp.2026.156423_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102963","article-title":"Arbutin alleviates fatty liver by inhibiting ferroptosis via FTO\/SLC7A11 pathway","volume":"68","author":"Jiang","year":"2023","journal-title":"Redox Biol."},{"issue":"14","key":"10.1016\/j.prp.2026.156423_bib112","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.7150\/ijbs.74546","article-title":"PHGDH inhibits ferroptosis and promotes malignant progression by upregulating SLC7A11 in bladder cancer","volume":"18","author":"Shen","year":"2022","journal-title":"Int J. Biol. Sci."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826000749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826000749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T14:38:55Z","timestamp":1785508735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033826000749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":112,"alternative-id":["S0344033826000749"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156423","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Astragaloside IV ameliorates experimental autoimmune myasthenia gravis through multi-target regulation of immune-microbiota-metabolism network and ferroptosis inhibition","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156423","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"156423"}}